发明名称 ASSAYS AND TREATMENTS FOR AUTOIMMUNE DISEASES
摘要 2074525 9111718 PCTABS00006 A specific method has been developed to identify the etiologic or immunogenic agent responsible for the production of autoantibodies characteristic of a particular disorder or immune response. The antigen is first isolated, then divided into overlapping short amino acid sequences. The sequences having the greatest reactivity with the autoantibodies are identified and compared with all known amino acid sequences using the available computer data bases. The protein having the maximum number of sequences homologous to the sequences of greatest reactivity with the autoantibodies is the likeliest candidate for the etiological agent. Applying this method, it has been determined that the etiological agent for the production of anti-Ro/SSA autoantibodies characteristic of numerous autoimmune diseases such as SLE appears to be a virus highly homologous to the Indiana strain of the vesicular stomatitis virus. Once the etiologic agent and antigenic sequences are known, it is possible to design assays and reagents for the diagnosis and treatment of patients having either the etiological agent and/or autoantibodies. An animal model has been developed for studying the mechanisms of, and screening compounds for the treatment or prevention of, the expression of these autoantibodies.
申请公布号 CA2074525(A1) 申请公布日期 1991.08.01
申请号 CA19912074525 申请日期 1991.01.31
申请人 REGENTS OF THE BOARD OF THE UNIVERSITY OF OKLAHOMA 发明人 HARLEY, JOHN B.
分类号 A61K39/00;A61K38/00;A61K39/205;A61P37/00;C07K14/145;C07K14/435;C07K14/47;C07K14/52;C07K14/555;C07K16/00;G01N33/53;G01N33/564;G01N33/569;G01N33/68;(IPC1-7):C07K14/145;A61K39/39 主分类号 A61K39/00
代理机构 代理人
主权项
地址